MarginsXMarginsX
Home › Markets › Health Care › SYK

Stryker Corporation (SYK)

SYK trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$310.72
+0.35% on the day
Market cap
$118.3B
Large cap
Revenue · 2025
$25.1B
+11.2% on 2024
Net income · 2025
$3.2B
12.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSYK on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000310764
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inMI

Financials · 2025

LineValue
Revenue$25.1B
Net income$3.2B
Operating income$4.9B
Net margin12.9%
Operating margin19.5%
Revenue growth+11.2%
Cash$4.0B
Total assets$47.8B
P/E (computed)36.4×
P/S (computed)4.7×

Warning signs

Cash runway
Cash-flow positive
$3.3B cash at September 30, 2026
Share count, 1 year
-0.5%
2025-09-30 to 2026-09-30 · +0.2% over 3 years
Going-concern doubt
No
10-Q filed October 30, 2026
Insider net buying, 12 months
-$586.1M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-30
Cash and burn$3.3B cash; operating cash flow $1.4B a quarter.Report 2026-09-30
Shares outstanding380,691,004 (2026-09-30); 382,423,648 a year earlier; 379,894,650 three years earlier.Cover page 2026-09-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-11-04
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2024-12-03
AuditorErnst & Young LLP, Grand Rapids, Michigan, United StatesPCAOB Form AP 2026-07-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $586.1M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$6.5B$753.0M$1.5B$3.3B$14.9B$26.3B10-Q 2026-10-30
Q2 2026
2026-06-30
$6.6B$1.3B$1.3B$3.4B$14.9B$25.8B10-Q 2026-07-31
Q1 2026
2026-03-31
$6.0B$745.0M$581.0M$2.9B$14.7B$25.3B10-Q 2026-05-11
Q4 2025
2025-12-31
$7.2B$849.0M$2.1B$4.0B$15.9B$25.1B10-K 2026-02-11
Q3 2025
2025-09-30
$6.1B$859.0M$1.5B$3.3B$16.6B$24.4B10-Q 2026-10-30
Q2 2025
2025-06-30
$6.0B$884.0M$1.1B$2.4B$16.6B$23.8B10-Q 2026-07-31
Q1 2025
2025-03-31
$5.9B$654.0M$250.0M$2.3B$16.8B$23.2B10-Q 2026-05-11
Q4 2024
2024-12-31
$6.4B$546.0M$1.9B$3.7B$13.6B$22.6B10-K 2026-02-11

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-11-04
Latest annual report10-K2026-02-11
Latest quarterly / interim10-Q2026-10-30
Latest current report8-K2026-11-09
Latest proxyDEFA14A2026-03-23

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-5.0%
1 month+9.6%
3 months-9.2%
Year to date-11.9%
1 year-17.1%
From 52-week high-20.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
MMM3M Company$181.68-1.08%$93.9B
BSXBoston Scientific Corporation$43.69-1.47%$63.3B
BDXBecton Dickinson and Company$216.47-0.72%$59.0B
MDLNMedline Inc.$39.17-0.76%$51.5B
RMDResMed Inc.$238.19-0.56%$33.5B
DXCMDexCom Inc.$81.61-2.06%$30.4B
WSTWest Pharmaceutical Services Inc.$417.80+0.33%$29.1B
SOLVSolventum Corporation$88.65-0.48%$15.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier